| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 80.70B | — |
| Operating expense | — | — |
| Net income | 4.43B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RDDA.F returned -17.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -12.1% |
| 1 year | -17.1% |
| 5 years | -1.1% |
| 10 years | +36.2% |
| All-time high | €15.00 (Dec 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in RDDA.F would be worth today ›Yes. Dr. Reddy's Laboratories Limited paid 1 dividend over the past 12 months. The most recent was €0.07 per share on Jul 9, 2026. The dividend yield is 0.70%.
Dr. Reddy's Laboratories Limited is part of the Healthcare sector.
Dr. Reddy's Laboratories Limited has a market cap of 8.58B EUR, based on the latest quote.
Dr. Reddy's Laboratories Limited is expected to report earnings around Oct 22, 2026. That date is an estimate and has not been confirmed by the company.
